d'Emmanuele di Villa Bianca Roberta, Marzocco Stefania, Di Paola Rosanna, Autore Giuseppina, Pinto Aldo, Cuzzocrea Salvatore, Sorrentino Raffaella
Dipartimento di Farmacologia Sperimentale, Università degli Studi di Napoli 'Federico II', Via D. Montesano, Napoli, Italy.
J Pineal Res. 2004 Apr;36(3):146-54. doi: 10.1046/j.1600-079x.2003.00111.x.
Melatonin (MT) is the principal secretory product of the pineal gland and its role as an immumo-modulator is well established. Recent evidence shows that MT exerts protective effects in septic shock, hemorrhagic shock and inflammation. Lipopolysaccharide (LPS), from Escherichia coli, administered to animals directly stimulates a number of cells and systems to produce various inflammatory mediators. LPS-induced septic shock is characterized by hypotension and vascular hyporeactivity to contracting agents. In particular, the reactive oxygen species such as superoxide and nitric oxide (NO) contribute to the pathophysiology of septic shock. In this study, we demonstrate that MT pretreatment prevents the hyporeactivity to phenylephrine in vivo and in aorta rings collected from rats treated with the endotoxin. The beneficial effect of MT seems related to its antioxidant properties and with inhibition of inducible nitric oxide synthase (iNOS) protein expression, reduction of NO production and nitrotyrosine formation, in aorta, preventing vascular, and endothelial injury. Additionally, we first demonstrate, that MT inhibited nuclear enzyme poly (ADP-ribose) synthetase activation in vascular tissue. The current study underlined the protective effect of MT on the vascular dysfunction associated with septic shock, data that could support the clinical use of MT in human endotoxemia.
褪黑素(MT)是松果体的主要分泌产物,其作为免疫调节剂的作用已得到充分证实。最近的证据表明,MT在脓毒性休克、失血性休克和炎症中发挥保护作用。给动物注射来自大肠杆菌的脂多糖(LPS)会直接刺激多种细胞和系统产生各种炎症介质。LPS诱导的脓毒性休克的特征是低血压和血管对收缩剂反应性降低。特别是,超氧化物和一氧化氮(NO)等活性氧参与了脓毒性休克的病理生理过程。在本研究中,我们证明MT预处理可预防体内以及从接受内毒素治疗的大鼠采集的主动脉环中对去氧肾上腺素的反应性降低。MT的有益作用似乎与其抗氧化特性以及抑制诱导型一氧化氮合酶(iNOS)蛋白表达、减少主动脉中NO生成和硝基酪氨酸形成有关,从而预防血管和内皮损伤。此外,我们首次证明,MT可抑制血管组织中核酶聚(ADP - 核糖)合成酶的激活。当前的研究强调了MT对与脓毒性休克相关的血管功能障碍的保护作用,这些数据可能支持MT在人类内毒素血症中的临床应用。